Boston Scientific Corp. (NYSE: BSX) stopped all shipments and issued a recall of its implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators sending the stock price tumbling $1.24 to $6.55.
Boston Scientific Halts Shipments, Recalls Defibrillators
March 15, 2010 at 13:33 PM EDT
